QFQiting Feng

Qiting Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qiting Feng has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Ling Li

    Department of Medical Information, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, 510080, China

    1 shared publication
  • Weizhong Yang

    Department of Ophthalmology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, 510080, China

    1 shared publication
  • Wenjian Mo

    Department of Hematology, Guangzhou First People's Hospital, Institute of Blood Transfusion and Hematology, Guangzhou Medical University, Guangzhou 510180, China

    1 shared publication
  • Xiangcai Ruan

    Department of Anesthesiology and Pain Medicine, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

    1 shared publication
  • Yuehong Zhang

    Department of Ophthalmology, Laboratory for Neuroimmunology in Health and Disease, Center for Medical Research on Innovation and Translation, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China

    1 shared publication
  • Zhuanhua Xian

    Department of Ophthalmology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, 510080, China

    1 shared publication

Latest Publications

  • Open Access

    High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation

    by Yuehong Zhang, Xiangcai Ruan, Weizhong Yang, Ling Li, Zhuanhua Xian, Qiting Feng, Wenjian Mo

    To summarize the clinical characteristics and potential factors affecting the visual outcomes in patients with cytomegalovirus retinitis following allogeneic haematopoietic stem cell transplantation (HSCT). This retrospective study enrolled 12 patients (19 eyes) with cytomegalovirus retinitis after HSCT at Guangzhou First People’s Hospital in China between January 2013 and December 2014. Demographic and clinical characteristics, ocular manifestations and visual outcomes were evaluated by reviewing medical records at the Departments of Hematology and Ophthalmology. All patients were followed up at least 6 months after stopping antiviral therapy. The visual outcome was defined as improvement, stabilization and deterioration. The subjects were composed of 7 human leucocyte antigen-matched and 5 mismatched receipts. All patients received combined systemic and intravitreous antiviral therapy. Eleven eyes gained improved or stabilized visual acuity, while 8 eyes suffered deterioration. Eyes with cytomegalovirus load less than 1 × 104 copies/ml in vitreous accounted for higher rate in eyes with good visual prognosis than those with cytomegalovirus copies above 1 × 104 copies/ml (52.63% vs 5.26%, P < 0.001). Human leucocyte antigen-matched receipts gained better visual prognosis than those mismatched ones (47.37% vs10.53%, P < 0.05). The virus types, cytomegalovirus peak in the blood, involved retinal zone and size had no influence on the visual outcomes (all P > 0.05). High ocular cytomegalovirus copies and mismatched receipts may be potential adverse factors affecting visual outcomes in cytomegalovirus retinitis patients following allogeneic HSCT.